Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
3(21%)
Results Posted
36%(4 trials)

Phase Distribution

Ph not_applicable
11
79%
Ph phase_2
2
14%
Ph phase_1
1
7%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
2(14.3%)
N/ANon-phased studies
11(78.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(11)

Detailed Status

Completed11
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (7.1%)
Phase 22 (14.3%)
N/A11 (78.6%)

Trials by Status

completed1179%
recruiting321%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14